Bioorganic & Medicinal Chemistry Letters · 2015 · 44 citations · 23 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryMolecular OncologyLigand BindingLigand-based DesignMolecular DockingPotency OptimizationReceptor Tyrosine Kinase SignalingTyrosine Kinase InhibitorsHer2 InhibitorsHer2 Receptor TargetingHer2 Targeting LigandsKinase Binding AssaysMolecular Docking AnalysisMolecular Docking Of InhibitorsSmall Molecule Tyrosine Kinase InhibitorsTargeted Kinase Inhibition
23
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
J. Guillermo Paez, Pasi A. Jänne, Jeffrey C. Lee et al. · Science · 2004 · 9.4K citations
<i>EGFR</i> Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
Susumu Kobayashi, Titus J. Boggon, Tajhal Dayaram et al. · New England Journal of Medicine · 2005 · 3.9K citations · Full text
Medicine, Oncology, Pharmacology +15